| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| PODD - Insulet Corporation | HOLD | 0 @ USD 310.67 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 310.67. The average price that PODD shares were previous bought at was USD 267.67. The current market price is 16.1% higher than average price they were purchased at. The value of the holding in PODD has increased by USD 1,769,446 compared to the previous valuation of Insulet Corporation however if the holding was sold on 2025-05-09 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | SELL | -25 @ USD 143.76 | USD -3,594 | The ETF sold 25 shares of DVA on 2025-05-09. The shares were previously bought for an average price of USD 154.462. The DaVita HealthCare Partners Inc shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 268 The average price that the ETF previously sold DVA share for is USD 153.875 which is higher than the selling price of USD 143.76 on 2025-05-09. |
| CRL - Creightons Plc | SELL | -28 @ USD 138.79 | USD -3,886 | The ETF sold 28 shares of CRL on 2025-05-09. The shares were previously bought for an average price of USD 168.426. The Creightons Plc shares were sold for -17.6% lower than average price of previous purchases. This resulted in an overall loss of USD 830 The average price that the ETF previously sold CRL share for is USD 190.623 which is higher than the selling price of USD 138.79 on 2025-05-09. |
| TECH - Bio-Techne Corp | SELL | -87 @ USD 49.94 | USD -4,345 | The ETF sold 87 shares of TECH on 2025-05-09. The shares were previously bought for an average price of USD 65.1559. The Bio-Techne Corp shares were sold for -23.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,324 The average price that the ETF previously sold TECH share for is USD 71.387 which is higher than the selling price of USD 49.94 on 2025-05-09. |
| MRNA - Moderna Inc | SELL | -184 @ USD 24.25 | USD -4,462 | The ETF sold 184 shares of MRNA on 2025-05-09. The shares were previously bought for an average price of USD 35.5024. The Moderna Inc shares were sold for -31.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,070 The average price that the ETF previously sold MRNA share for is USD 42.2248 which is higher than the selling price of USD 24.25 on 2025-05-09. |
| HSIC - Henry Schein Inc | SELL | -69 @ USD 68.64 | USD -4,736 | The ETF sold 69 shares of HSIC on 2025-05-09. The shares were previously bought for an average price of USD 72.8579. The Henry Schein Inc shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 291 The average price that the ETF previously sold HSIC share for is USD 71.121 which is higher than the selling price of USD 68.64 on 2025-05-09. |
| SOLV - Solventum Corp. | SELL | -74 @ USD 70.23 | USD -5,197 | The ETF sold 74 shares of SOLV on 2025-05-09. The shares were previously bought for an average price of USD 74.1544. The Solventum Corp. shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 290 The average price that the ETF previously sold SOLV share for is USD 70.1909 so the ETF has sold 74 shares on 2025-05-09 at a higher price than the previous selling average. |
| INCY - Incyte Corporation | SELL | -89 @ USD 58.98 | USD -5,249 | The ETF sold 89 shares of INCY on 2025-05-09. The shares were previously bought for an average price of USD 69.0781. The Incyte Corporation shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of USD 899 The average price that the ETF previously sold INCY share for is USD 72.9222 which is higher than the selling price of USD 58.98 on 2025-05-09. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 181.78 | USD -5,635 | The ETF sold 31 shares of UHS on 2025-05-09. The shares were previously bought for an average price of USD 189.037. The Universal Health Services Inc shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of USD 225 The average price that the ETF previously sold UHS share for is USD 192.768 which is higher than the selling price of USD 181.78 on 2025-05-09. |
| VTRS - Viatris Inc | SELL | -668 @ USD 8.77 | USD -5,858 | The ETF sold 668 shares of VTRS on 2025-05-09. The shares were previously bought for an average price of USD 10.4127. The Viatris Inc shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,097 The average price that the ETF previously sold VTRS share for is USD 12.2756 which is higher than the selling price of USD 8.77 on 2025-05-09. |
| RVTY - Revvity Inc. | SELL | -68 @ USD 91.25 | USD -6,205 | The ETF sold 68 shares of RVTY on 2025-05-09. The shares were previously bought for an average price of USD 112.119. The Revvity Inc. shares were sold for -18.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,419 The average price that the ETF previously sold RVTY share for is USD 114.519 which is higher than the selling price of USD 91.25 on 2025-05-09. |
| HOLX - Hologic Inc | SELL | -124 @ USD 56.75 | USD -7,037 | The ETF sold 124 shares of HOLX on 2025-05-09. The shares were previously bought for an average price of USD 66.9948. The Hologic Inc shares were sold for -15.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,270 The average price that the ETF previously sold HOLX share for is USD 72.6689 which is higher than the selling price of USD 56.75 on 2025-05-09. |
| ALGN - Align Technology Inc | SELL | -39 @ USD 181.88 | USD -7,093 | The ETF sold 39 shares of ALGN on 2025-05-09. The shares were previously bought for an average price of USD 188.249. The Align Technology Inc shares were sold for -3.4% lower than average price of previous purchases. This resulted in an overall loss of USD 248 The average price that the ETF previously sold ALGN share for is USD 216.298 which is higher than the selling price of USD 181.88 on 2025-05-09. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 213.06 | USD -8,309 | The ETF sold 39 shares of WST on 2025-05-09. The shares were previously bought for an average price of USD 256.749. The West Pharmaceutical Services Inc shares were sold for -17.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,704 The average price that the ETF previously sold WST share for is USD 307.453 which is higher than the selling price of USD 213.06 on 2025-05-09. |
| BAX - Baxter International Inc | SELL | -280 @ USD 30.9 | USD -8,652 | The ETF sold 280 shares of BAX on 2025-05-09. The shares were previously bought for an average price of USD 33.3451. The Baxter International Inc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 685 The average price that the ETF previously sold BAX share for is USD 32.4861 which is higher than the selling price of USD 30.9 on 2025-05-09. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -112 @ USD 82.27 | USD -9,214 | The ETF sold 112 shares of COO on 2025-05-09. The shares were previously bought for an average price of USD 89.1555. The The Cooper Companies, Inc. Common Stock shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 771 The average price that the ETF previously sold COO share for is USD 96.5603 which is higher than the selling price of USD 82.27 on 2025-05-09. |
| BIIB - Biogen Inc | SELL | -80 @ USD 118.17 | USD -9,454 | The ETF sold 80 shares of BIIB on 2025-05-09. The shares were previously bought for an average price of USD 145.895. The Biogen Inc shares were sold for -19.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,218 The average price that the ETF previously sold BIIB share for is USD 158.909 which is higher than the selling price of USD 118.17 on 2025-05-09. |
| MOH - MOH | SELL | -30 @ USD 322.2 | USD -9,666 | The ETF sold 30 shares of MOH on 2025-05-09. The shares were previously bought for an average price of USD 309.466. The MOH shares were sold for 4.1% higher than average price of previous purchases. This sale made a profit of USD 382 The average price that the ETF previously sold MOH share for is USD 306.294 so the ETF has sold 30 shares on 2025-05-09 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 322.2 | USD -9,666 | The ETF sold 30 shares of MOH on 2025-05-09. The shares were previously bought for an average price of USD 309.466. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 4.1% higher than average price of previous purchases. This sale made a profit of USD 382 The average price that the ETF previously sold MOH share for is USD 306.294 so the ETF has sold 30 shares on 2025-05-09 at a higher price than the previous selling average. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -109 @ USD 95.21 | USD -10,378 | The ETF sold 109 shares of ZBH on 2025-05-09. The shares were previously bought for an average price of USD 107.208. The Zimmer Biomet Holdings Inc shares were sold for -11.2% lower than average price of previous purchases. This resulted in an overall loss of USD 1,308 The average price that the ETF previously sold ZBH share for is USD 107.659 which is higher than the selling price of USD 95.21 on 2025-05-09. |
| DGX - Quest Diagnostics Incorporated | SELL | -62 @ USD 176.96 | USD -10,972 | The ETF sold 62 shares of DGX on 2025-05-09. The shares were previously bought for an average price of USD 166.941. The Quest Diagnostics Incorporated shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 621 The average price that the ETF previously sold DGX share for is USD 158.98 so the ETF has sold 62 shares on 2025-05-09 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -32 @ USD 344.06 | USD -11,010 | The ETF sold 32 shares of WAT on 2025-05-09. The shares were previously bought for an average price of USD 369.375. The Waters Corporation shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 810 The average price that the ETF previously sold WAT share for is USD 373.152 which is higher than the selling price of USD 344.06 on 2025-05-09. |
| WAT - MULETFWATIMETFP | SELL | -32 @ USD 344.06 | USD -11,010 | The ETF sold 32 shares of WAT on 2025-05-09. The shares were previously bought for an average price of USD 369.375. The MULETFWATIMETFP shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 810 The average price that the ETF previously sold WAT share for is USD 373.152 which is higher than the selling price of USD 344.06 on 2025-05-09. |
| LH - Laboratory Corporation of America Holdings | SELL | -45 @ USD 245.73 | USD -11,058 | The ETF sold 45 shares of LH on 2025-05-09. The shares were previously bought for an average price of USD 241.187. The Laboratory Corporation of America Holdings shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of USD 204 The average price that the ETF previously sold LH share for is USD 235.737 so the ETF has sold 45 shares on 2025-05-09 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1080.98 | USD -11,891 | The ETF sold 11 shares of MTD on 2025-05-09. The shares were previously bought for an average price of USD 1240.07. The Mettler-Toledo International Inc shares were sold for -12.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,750 The average price that the ETF previously sold MTD share for is USD 1242.73 which is higher than the selling price of USD 1080.98 on 2025-05-09. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1080.98 | USD -11,891 | The ETF sold 11 shares of MTD on 2025-05-09. The shares were previously bought for an average price of USD 1240.07. The AMUNDI EUR GOV 710 shares were sold for -12.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,750 The average price that the ETF previously sold MTD share for is USD 1242.73 which is higher than the selling price of USD 1080.98 on 2025-05-09. |
| STE - STERIS plc | SELL | -54 @ USD 226.43 | USD -12,227 | The ETF sold 54 shares of STE on 2025-05-09. The shares were previously bought for an average price of USD 221.998. The STERIS plc shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 239 The average price that the ETF previously sold STE share for is USD 214.675 so the ETF has sold 54 shares on 2025-05-09 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -92 @ USD 148.99 | USD -13,707 | The ETF sold 92 shares of IQV on 2025-05-09. The shares were previously bought for an average price of USD 192.104. The IQVIA Holdings Inc shares were sold for -22.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,966 The average price that the ETF previously sold IQV share for is USD 198.915 which is higher than the selling price of USD 148.99 on 2025-05-09. |
| HUM - Hummingbird Resources PLC | SELL | -66 @ USD 249.53 | USD -16,469 | The ETF sold 66 shares of HUM on 2025-05-09. The shares were previously bought for an average price of USD 270.499. The Hummingbird Resources PLC shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,384 The average price that the ETF previously sold HUM share for is USD 278.607 which is higher than the selling price of USD 249.53 on 2025-05-09. |
| HUM - Humana Inc | SELL | -66 @ USD 249.53 | USD -16,469 | The ETF sold 66 shares of HUM on 2025-05-09. The shares were previously bought for an average price of USD 270.499. The Humana Inc shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,384 The average price that the ETF previously sold HUM share for is USD 278.607 which is higher than the selling price of USD 249.53 on 2025-05-09. |
| A - Agilent Technologies Inc | SELL | -157 @ USD 106.93 | USD -16,788 | The ETF sold 157 shares of A on 2025-05-09. The shares were previously bought for an average price of USD 129.061. The Agilent Technologies Inc shares were sold for -17.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,475 The average price that the ETF previously sold A share for is USD 133.188 which is higher than the selling price of USD 106.93 on 2025-05-09. |
| CNC - Concurrent Technologies Plc | SELL | -276 @ USD 62.79 | USD -17,330 | The ETF sold 276 shares of CNC on 2025-05-09. The shares were previously bought for an average price of USD 60.1309. The Concurrent Technologies Plc shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 734 The average price that the ETF previously sold CNC share for is USD 60.0589 so the ETF has sold 276 shares on 2025-05-09 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -251 @ USD 69.87 | USD -17,537 | The ETF sold 251 shares of GEHC on 2025-05-09. The shares were previously bought for an average price of USD 84.9532. The GE HealthCare Technologies Inc. shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,786 The average price that the ETF previously sold GEHC share for is USD 81.5278 which is higher than the selling price of USD 69.87 on 2025-05-09. |
| DXCM - DexCom Inc | SELL | -216 @ USD 84.67 | USD -18,289 | The ETF sold 216 shares of DXCM on 2025-05-09. The shares were previously bought for an average price of USD 77.823. The DexCom Inc shares were sold for 8.8% higher than average price of previous purchases. This sale made a profit of USD 1,479 The average price that the ETF previously sold DXCM share for is USD 75.2911 so the ETF has sold 216 shares on 2025-05-09 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -80 @ USD 245.04 | USD -19,603 | The ETF sold 80 shares of RMD on 2025-05-09. The shares were previously bought for an average price of USD 234.079. The ResMed Inc shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 877 The average price that the ETF previously sold RMD share for is USD 239.764 so the ETF has sold 80 shares on 2025-05-09 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -133 @ USD 148.22 | USD -19,713 | The ETF sold 133 shares of CAH on 2025-05-09. The shares were previously bought for an average price of USD 128.132. The Cardinal Health Inc shares were sold for 15.7% higher than average price of previous purchases. This sale made a profit of USD 2,672 The average price that the ETF previously sold CAH share for is USD 121.515 so the ETF has sold 133 shares on 2025-05-09 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 491.7 | USD -21,635 | The ETF sold 44 shares of IDXX on 2025-05-09. The shares were previously bought for an average price of USD 440.043. The IDEXX Laboratories Inc shares were sold for 11.7% higher than average price of previous purchases. This sale made a profit of USD 2,273 The average price that the ETF previously sold IDXX share for is USD 424.852 so the ETF has sold 44 shares on 2025-05-09 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -324 @ USD 73.68 | USD -23,872 | The ETF sold 324 shares of EW on 2025-05-09. The shares were previously bought for an average price of USD 71.2364. The Edwards Lifesciences Corp shares were sold for 3.4% higher than average price of previous purchases. This sale made a profit of USD 792 The average price that the ETF previously sold EW share for is USD 70.165 so the ETF has sold 324 shares on 2025-05-09 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -157 @ USD 167.22 | USD -26,254 | The ETF sold 157 shares of BDX on 2025-05-09. The shares were previously bought for an average price of USD 227.153. The Becton Dickinson and Company shares were sold for -26.4% lower than average price of previous purchases. This resulted in an overall loss of USD 9,409 The average price that the ETF previously sold BDX share for is USD 225.525 which is higher than the selling price of USD 167.22 on 2025-05-09. |
| COR - Cencora Inc. | SELL | -94 @ USD 283 | USD -26,602 | The ETF sold 94 shares of COR on 2025-05-09. The shares were previously bought for an average price of USD 254.355. The Cencora Inc. shares were sold for 11.3% higher than average price of previous purchases. This sale made a profit of USD 2,693 The average price that the ETF previously sold COR share for is USD 244.879 so the ETF has sold 94 shares on 2025-05-09 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -57 @ USD 527.78 | USD -30,083 | The ETF sold 57 shares of REGN on 2025-05-09. The shares were previously bought for an average price of USD 705.875. The Regeneron Pharmaceuticals Inc shares were sold for -25.2% lower than average price of previous purchases. This resulted in an overall loss of USD 10,151 The average price that the ETF previously sold REGN share for is USD 755.016 which is higher than the selling price of USD 527.78 on 2025-05-09. |
| HCA - HCA Holdings Inc | SELL | -97 @ USD 353.7 | USD -34,309 | The ETF sold 97 shares of HCA on 2025-05-09. The shares were previously bought for an average price of USD 337.635. The HCA Holdings Inc shares were sold for 4.8% higher than average price of previous purchases. This sale made a profit of USD 1,558 The average price that the ETF previously sold HCA share for is USD 325.786 so the ETF has sold 97 shares on 2025-05-09 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -244 @ USD 159.27 | USD -38,862 | The ETF sold 244 shares of ZTS on 2025-05-09. The shares were previously bought for an average price of USD 167.299. The Zoetis Inc shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,959 The average price that the ETF previously sold ZTS share for is USD 172.075 which is higher than the selling price of USD 159.27 on 2025-05-09. |
| CVS - CVS Health Corp | SELL | -688 @ USD 66.97 | USD -46,075 | The ETF sold 688 shares of CVS on 2025-05-09. The shares were previously bought for an average price of USD 62.9476. The CVS Health Corp shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 2,767 The average price that the ETF previously sold CVS share for is USD 55.1404 so the ETF has sold 688 shares on 2025-05-09 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -68 @ USD 693.46 | USD -47,155 | The ETF sold 68 shares of MCK on 2025-05-09. The shares were previously bought for an average price of USD 620.784. The McKesson Corporation shares were sold for 11.7% higher than average price of previous purchases. This sale made a profit of USD 4,942 The average price that the ETF previously sold MCK share for is USD 599.371 so the ETF has sold 68 shares on 2025-05-09 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -149 @ USD 333.46 | USD -49,686 | The ETF sold 149 shares of CI on 2025-05-09. The shares were previously bought for an average price of USD 316.945. The Cigna Corp shares were sold for 5.2% higher than average price of previous purchases. This sale made a profit of USD 2,461 The average price that the ETF previously sold CI share for is USD 312.837 so the ETF has sold 149 shares on 2025-05-09 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 404.58 | USD -50,573 | The ETF sold 125 shares of ELV on 2025-05-09. The shares were previously bought for an average price of USD 411.153. The Elevance Health Inc shares were sold for -1.6% lower than average price of previous purchases. This resulted in an overall loss of USD 822 The average price that the ETF previously sold ELV share for is USD 402.478 so the ETF has sold 125 shares on 2025-05-09 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -125 @ USD 404.58 | USD -50,573 | The ETF sold 125 shares of ELV on 2025-05-09. The shares were previously bought for an average price of USD 411.153. The Elevance Health Inc shares were sold for -1.6% lower than average price of previous purchases. This resulted in an overall loss of USD 822 The average price that the ETF previously sold ELV share for is USD 402.478 so the ETF has sold 125 shares on 2025-05-09 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,106 @ USD 46.45 | USD -51,374 | The ETF sold 1106 shares of BMY on 2025-05-09. The shares were previously bought for an average price of USD 57.4299. The Bloomsbury Publishing Plc shares were sold for -19.1% lower than average price of previous purchases. This resulted in an overall loss of USD 12,144 The average price that the ETF previously sold BMY share for is USD 56.8887 which is higher than the selling price of USD 46.45 on 2025-05-09. |
| MDT - Medtronic PLC | SELL | -698 @ USD 83.48 | USD -58,269 | The ETF sold 698 shares of MDT on 2025-05-09. The shares were previously bought for an average price of USD 88.786. The Medtronic PLC shares were sold for -6.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,704 The average price that the ETF previously sold MDT share for is USD 85.4012 which is higher than the selling price of USD 83.48 on 2025-05-09. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -139 @ USD 424.99 | USD -59,074 | The ETF sold 139 shares of VRTX on 2025-05-09. The shares were previously bought for an average price of USD 479.172. The Vertex Pharmaceuticals Inc shares were sold for -11.3% lower than average price of previous purchases. This resulted in an overall loss of USD 7,531 The average price that the ETF previously sold VRTX share for is USD 465.014 which is higher than the selling price of USD 424.99 on 2025-05-09. |
| GILD - Guild Esports Plc | SELL | -678 @ USD 96.91 | USD -65,705 | The ETF sold 678 shares of GILD on 2025-05-09. The shares were previously bought for an average price of USD 103.008. The Guild Esports Plc shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,134 The average price that the ETF previously sold GILD share for is USD 94.241 so the ETF has sold 678 shares on 2025-05-09 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -348 @ USD 189.73 | USD -66,026 | The ETF sold 348 shares of DHR on 2025-05-09. The shares were previously bought for an average price of USD 216.905. The Danaher Corporation shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,457 The average price that the ETF previously sold DHR share for is USD 232.832 which is higher than the selling price of USD 189.73 on 2025-05-09. |
| DHR - Danaher Corporation | SELL | -348 @ USD 189.73 | USD -66,026 | The ETF sold 348 shares of DHR on 2025-05-09. The shares were previously bought for an average price of USD 216.905. The Danaher Corporation shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,457 The average price that the ETF previously sold DHR share for is USD 232.832 which is higher than the selling price of USD 189.73 on 2025-05-09. |
| PFE - Pfizer Inc | SELL | -3,085 @ USD 22.28 | USD -68,734 | The ETF sold 3085 shares of PFE on 2025-05-09. The shares were previously bought for an average price of USD 25.8383. The Pfizer Inc shares were sold for -13.8% lower than average price of previous purchases. This resulted in an overall loss of USD 10,977 The average price that the ETF previously sold PFE share for is USD 26.0605 which is higher than the selling price of USD 22.28 on 2025-05-09. |
| SYK - Stryker Corporation | SELL | -187 @ USD 380.92 | USD -71,232 | The ETF sold 187 shares of SYK on 2025-05-09. The shares were previously bought for an average price of USD 379.646. The Stryker Corporation shares were sold for 0.3% higher than average price of previous purchases. This sale made a profit of USD 238 The average price that the ETF previously sold SYK share for is USD 374.42 so the ETF has sold 187 shares on 2025-05-09 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -292 @ USD 265.86 | USD -77,631 | The ETF sold 292 shares of AMGN on 2025-05-09. The shares were previously bought for an average price of USD 303.576. The Amgen Inc shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 11,013 The average price that the ETF previously sold AMGN share for is USD 289.995 which is higher than the selling price of USD 265.86 on 2025-05-09. |
| BSX - Boston Scientific Corporation | SELL | -802 @ USD 102.86 | USD -82,494 | The ETF sold 802 shares of BSX on 2025-05-09. The shares were previously bought for an average price of USD 98.639. The Boston Scientific Corporation shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 3,385 The average price that the ETF previously sold BSX share for is USD 90.0286 so the ETF has sold 802 shares on 2025-05-09 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -802 @ USD 102.86 | USD -82,494 | The ETF sold 802 shares of BSX on 2025-05-09. The shares were previously bought for an average price of USD 98.639. The MULSTRXSSXIMETFP shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 3,385 The average price that the ETF previously sold BSX share for is USD 90.0286 so the ETF has sold 802 shares on 2025-05-09 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -208 @ USD 403.13 | USD -83,851 | The ETF sold 208 shares of TMO on 2025-05-09. The shares were previously bought for an average price of USD 522.753. The Time Out Group plc shares were sold for -22.9% lower than average price of previous purchases. This resulted in an overall loss of USD 24,882 The average price that the ETF previously sold TMO share for is USD 526.069 which is higher than the selling price of USD 403.13 on 2025-05-09. |
| ISRG - Intuitive Surgical Inc | SELL | -193 @ USD 536.51 | USD -103,546 | The ETF sold 193 shares of ISRG on 2025-05-09. The shares were previously bought for an average price of USD 540.857. The Intuitive Surgical Inc shares were sold for -0.8% lower than average price of previous purchases. This resulted in an overall loss of USD 839 The average price that the ETF previously sold ISRG share for is USD 529.713 so the ETF has sold 193 shares on 2025-05-09 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -1,375 @ USD 75.97 | USD -104,459 | The ETF sold 1375 shares of MRK on 2025-05-09. The shares were previously bought for an average price of USD 92.0355. The Marks Electrical Group PLC shares were sold for -17.5% lower than average price of previous purchases. This resulted in an overall loss of USD 22,090 The average price that the ETF previously sold MRK share for is USD 99.4308 which is higher than the selling price of USD 75.97 on 2025-05-09. |
| MRK - Merck & Company Inc | SELL | -1,375 @ USD 75.97 | USD -104,459 | The ETF sold 1375 shares of MRK on 2025-05-09. The shares were previously bought for an average price of USD 92.0355. The Merck & Company Inc shares were sold for -17.5% lower than average price of previous purchases. This resulted in an overall loss of USD 22,090 The average price that the ETF previously sold MRK share for is USD 99.4308 which is higher than the selling price of USD 75.97 on 2025-05-09. |
| ABT - Abbott Laboratories | SELL | -942 @ USD 133.24 | USD -125,512 | The ETF sold 942 shares of ABT on 2025-05-09. The shares were previously bought for an average price of USD 127.012. The Abbott Laboratories shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of USD 5,867 The average price that the ETF previously sold ABT share for is USD 117.31 so the ETF has sold 942 shares on 2025-05-09 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -958 @ USD 184.6 | USD -176,847 | The ETF sold 958 shares of ABBV on 2025-05-09. The shares were previously bought for an average price of USD 193.617. The AbbVie Inc shares were sold for -4.7% lower than average price of previous purchases. This resulted in an overall loss of USD 8,638 The average price that the ETF previously sold ABBV share for is USD 185.255 which is higher than the selling price of USD 184.6 on 2025-05-09. |
| UNH - UnitedHealth Group Incorporated | SELL | -499 @ USD 380.64 | USD -189,939 | The ETF sold 499 shares of UNH on 2025-05-09. The shares were previously bought for an average price of USD 526.426. The UnitedHealth Group Incorporated shares were sold for -27.7% lower than average price of previous purchases. This resulted in an overall loss of USD 72,747 The average price that the ETF previously sold UNH share for is USD 564.978 which is higher than the selling price of USD 380.64 on 2025-05-09. |
| JNJ - Johnson & Johnson | SELL | -1,307 @ USD 154.22 | USD -201,566 | The ETF sold 1307 shares of JNJ on 2025-05-09. The shares were previously bought for an average price of USD 158.082. The Johnson & Johnson shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of USD 5,048 The average price that the ETF previously sold JNJ share for is USD 152.717 so the ETF has sold 1307 shares on 2025-05-09 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -427 @ USD 734.57 | USD -313,661 | The ETF sold 427 shares of LLY on 2025-05-09. The shares were previously bought for an average price of USD 838.631. The Eli Lilly and Company shares were sold for -12.4% lower than average price of previous purchases. This resulted in an overall loss of USD 44,434 The average price that the ETF previously sold LLY share for is USD 796.929 which is higher than the selling price of USD 734.57 on 2025-05-09. |